Davallia formosana
Davallia formosana · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Davallia formosana is a medicinal plant that has gained significant attention for its diverse therapeutic potential. Scientific studies focusing on its root and stem components have revealed promising antidiabetic and antiosteoporotic activities. Specifically, preparations such as the ethanolic extract and DFE have demonstrated effectiveness in managing blood glucose levels and addressing dyslipidemia. Furthermore, the plant shows great promise in treating hyperlipidemia and various bone diseases. These findings highlight the importance of exploring this species for the development of new pharmacological treatments.
- Synonyms
- Wibelia Formosana
- Common names
- Not available
- Family
- Polypodiaceae
- Distribution
- Not available
- Plant Parts
- Root · Stem
Classification
Synonyms
Davallia formosana is a distinctive fern species that is frequently identified in botanical literature by its synonym, Wibelia formosana. While these two names refer to the same biological entity, understanding this nomenclatural link is essential for accurate plant identification. Researchers and collectors often encounter both terms when searching through historical archives or modern databases. Recognizing that Wibelia formosana is simply another way to classify this plant ensures consistency in scientific communication. Therefore, maintaining awareness of these synonymous relationships is vital for anyone studying the diverse world of ferns.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Davallia formosana is a unique specimen that belongs to the vast kingdom Plantae. Within this biological realm, it is classified under the class Equisetopsida. It further falls into the order Polypodiales, showcasing its evolutionary lineage. As a member of the family Polypodiaceae, it shares characteristics with many other diverse ferns. Ultimately, this plant is identified by its specific genus, Davallia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Polypodiinae |
| Order | Polypodiales |
| Family | Polypodiaceae |
| Genus | Davallia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Davallia formosana is a specialized fern species primarily found within the temperate regions of Asia. Its natural range extends through various parts of China, including the lush landscapes of Southeast China. Additionally, this plant maintains a significant presence throughout Eastern Asia, specifically across the island of Taiwan. These diverse geographical pockets provide the unique environmental conditions necessary for its continued survival. Understanding these specific distribution patterns is essential for studying the plant's ecological role in its native habitats.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Davallia formosana demonstrates significant medicinal potential through its diverse therapeutic activities. Research indicates that the compound (-)-epicatechin-3-O-β-D-allopyranoside derived from this plant possesses potent antidiabetic properties by regulating glucose transporters and insulin levels. Furthermore, the plant exhibits notable antiosteoporotic activity, which has long been recognized in Taiwanese folk medicine for treating bone diseases. Studies have shown that extracts from the plant can effectively inhibit osteoclast differentiation and prevent significant bone loss in animal models. Ultimately, these findings suggest that Davallia formosana may serve as a valuable natural remedy for managing both type 2 diabetes and osteoporosis.
Compounds
Conditions
Davallia formosana contains (-)-epicatechin-3-O-β-D-allopyranoside, which effectively treats diabetes by significantly decreasing blood glucose levels. The plant also treats hyperlipidemia by reducing triglyceride and insulin concentrations in the blood. Through its biological mechanisms, Davallia formosana treats muscular membrane protein levels of glucose transporter 4 (GLUT4) by significantly enhancing their expression. Additionally, the plant treats adiponectin levels by reversing the decreases caused by a high-fat diet. These combined effects demonstrate that Davallia formosana treats blood glucose and metabolic imbalances in animal models.
Preparations
Davallia formosana is prepared as an ethanolic extract to investigate its therapeutic potential. This specific substance is also referred to as DFE within the study. Researchers utilized DFE to evaluate anti-osteoporotic effects and its impact on bone metabolism. The preparation of DFE allows for the isolation of active components like ECAP to ensure quality control. Ultimately, the study focuses on how DFE serves as a medicinal remedy for bone reabsorption diseases.
Parts used
Davallia formosana is a plant of significant medicinal interest due to the bioactive compounds found within its physical structure. Specifically, researchers have identified that both the root and the stem of this species contain the compound (-)-epicatechin-3-O-β-D-allopyranoside. This particular substance, often referred to as BB, has demonstrated remarkable potential in managing metabolic health. In experimental models, the extract from these plant parts helped significantly decrease blood glucose, triglyceride, and insulin levels. Ultimately, the chemical properties derived from the roots and stems of Davallia formosana offer a promising approach for treating type 2 diabetes and dyslipidemia.